Trean Insurance Group (TIG) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trean Insurance Group in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TIG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TIG, but not buy additional shares or sell existing shares.
View TIG analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 12-month price targets for Trean Insurance Group's shares. Their TIG share price forecasts range from $5.50 to $5.50. On average, they expect the company's share price to reach $5.50 in the next twelve months. This suggests that the stock has a possible downside of 10.7%.
View analysts price targets for TIG or view top-rated stocks among Wall Street analysts.

Trean Insurance Group, Inc. (NASDAQ:TIG) issued its quarterly earnings data on Wednesday, November, 10th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.20 by $0.05. The company had revenue of $56.94 million for the quarter, compared to the consensus estimate of $59.64 million. Trean Insurance Group had a negative net margin of 21.75% and a positive trailing twelve-month return on equity of 2.04%. During the same quarter in the prior year, the business posted $0.21 EPS.

42 employees have rated Trean Insurance Group Chief Executive Officer Tim Griffiths on Glassdoor.com. Tim Griffiths has an approval rating of 45% among the company's employees. This puts Tim Griffiths in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trean Insurance Group investors own include Editas Medicine (EDIT), Agenus (AGEN), Pharming Group (PHGUF), Galapagos (GLPG), NewLink Genetics (NLNK), ING Groep (ING), Cytori Therapeutics (CYTX), Hemispherx BioPharma (HEB), Teva Pharmaceutical Industries (TEVA) and Ultra Clean (UCTT).

(TIG) raised $150 million in an IPO on Thursday, July 16th 2020. The company issued 10,700,000 shares at $13.00-$15.00 per share. J.P. Morgan, Evercore ISI and William Blair served as the underwriters for the IPO and JMP Securities was co-manager.

Trean Insurance Group trades on the NASDAQ under the ticker symbol "TIG."

Trean Insurance Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%). Insiders that own company stock include Altaris Partners, Llc, Andrew O'brien, Jennifer Bealer, Julie A Baron, Matthew James Spencer, Nicholas J Vassallo, Patricia A Ryan and Steven B Lee.
View institutional ownership trends.

One share of TIG stock can currently be purchased for approximately $6.16.

Trean Insurance Group (NASDAQ:TIG) has a market capitalization of $315.64 million and generates $303.24 million in revenue each year. The company earns $-65,960,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis.

The company employs 355 workers across the globe.

Trean Insurance Group's mailing address is 150 LAKE STREET WEST, WAYZATA MN, 55391. The official website for the company is www.trean.com. The company can be reached via phone at 952-974-2200 or via email at investor.relations@trean.com.